It might be suggested that TFPI, being the main inhibitor of TF, would be consumed during a hypercoagulable state, such as in acute coronary syndrome (ACS) or strenuous exercise, or even to an increased extent when the two coincide. The gene discussed is TF; the disease is acute coronary syndrome.